amifostine anhydrous has been researched along with Experimental Leukemia in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Valeriote, F | 1 |
Tolen, S | 1 |
Antoku, S | 1 |
DeNeve, WJ | 1 |
Everett, CK | 1 |
Suminski, JE | 1 |
Valeriote, FA | 1 |
3 other studies available for amifostine anhydrous and Experimental Leukemia
Article | Year |
---|---|
Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
Topics: Amifostine; Animals; Cell Survival; Drug Interactions; Drug Synergism; Hematopoietic Stem Cells; Leu | 1982 |
Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
Topics: Amifostine; Animals; Cells, Cultured; Cobalt Radioisotopes; Cysteamine; Dose-Response Relationship, | 1983 |
Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
Topics: Amifostine; Animals; Bone Marrow; DNA; DNA Damage; Female; Leukemia, Experimental; Male; Mechloretha | 1988 |